Department of Medicine, University of Alberta, Edmonton, Alta.
CMAJ. 2011 Oct 4;183(14):E1059-66. doi: 10.1503/cmaj.110387. Epub 2011 Aug 15.
Anthropometric-based classification schemes for excess adiposity do not include direct assessment of obesity-related comorbidity and functional status and thus have limited clinical utility. We examined the ability of the Edmonton obesity staging system, a 5-point ordinal classification system that considers comorbidity and functional status, in predicting mortality in a nationally representative US sample.
We analyzed data from the National Health and Human Nutrition Examination Surveys (NHANES) III (1988-1994) and the NHANES 1999-2004, with mortality follow-up through to the end of 2006. Adults (age ≥ 20 yr) with overweight or obesity who had been randomized to the morning session at the mobile examination centre were scored according to the Edmonton obesity staging system. We examined the relationship between staging system scores and mortality, and Cox proportional hazards models were adjusted for the presence of the metabolic syndrome or hypertriglyceridemic waist.
Over 75% of the cohort with overweight or obesity were given scores of 1 or 2. Scores of 4 could not be reliably assigned because specific data elements were lacking. Survival curves clearly diverged when stratified by scores of 0-3, but not when stratified by obesity class alone. Within the data from the NHANES 1988-1994, scores of 2 (hazard ratio [HR] 1.57; 95% confidence interval [CI] 1.16 to 2.13) and 3 (HR 2.69; 95% CI 1.98 to 3.67) were associated with increased mortality compared with scores of 0 or 1, even after adjustment for body mass index and the metabolic syndrome. We found similar results after adjusting for hypertriglyceridemic waist (i.e., waist circumference ≥ 90 cm and a triglyceride level ≥ 2 mmol/L for men; the corresponding values for women were ≥ 85 cm and ≥ 1.5 mmol/L), as well as in a cohort eligible for bariatric surgery.
The Edmonton obesity staging system independently predicted increased mortality even after adjustment for contemporary methods of classifying adiposity. The Edmonton obesity staging system may offer improved clinical utility in assessing obesity-related risk and prioritizing treatment.
基于人体测量的超重分类方案不包括对肥胖相关并发症和功能状态的直接评估,因此临床应用有限。我们检验了埃德蒙顿肥胖分期系统的能力,这是一种 5 分序分类系统,考虑了并发症和功能状态,在预测具有全国代表性的美国样本的死亡率方面。
我们分析了来自国家健康和人类营养调查(NHANES)III(1988-1994 年)和 NHANES 1999-2004 年的数据,通过 2006 年底的死亡率随访。在移动体检中心接受晨间检查的超重或肥胖成年人,根据埃德蒙顿肥胖分期系统进行评分。我们研究了分期系统评分与死亡率之间的关系,Cox 比例风险模型调整了代谢综合征或高三酰甘油性腰围的存在。
超过 75%的超重或肥胖队列被给予 1 或 2 分的评分。4 分不能可靠地分配,因为缺乏特定的数据元素。根据分数 0-3 分层时,生存曲线明显不同,但根据肥胖程度单独分层时则不然。在 NHANES 1988-1994 年的数据中,与分数 0 或 1 相比,分数 2(危险比 [HR] 1.57;95%置信区间 [CI] 1.16 至 2.13)和 3(HR 2.69;95% CI 1.98 至 3.67)与死亡率增加相关,即使在调整了体重指数和代谢综合征后也是如此。我们在调整了高三酰甘油性腰围(即男性腰围≥90cm,三酰甘油水平≥2mmol/L;女性相应值分别为≥85cm 和≥1.5mmol/L)和有资格接受减肥手术的队列后,发现了类似的结果。
埃德蒙顿肥胖分期系统独立预测死亡率增加,即使在调整了当代肥胖分类方法后也是如此。埃德蒙顿肥胖分期系统在评估肥胖相关风险和确定治疗优先级方面可能具有更好的临床实用性。